List of works by Martin Marquis

An NS3 serine protease inhibitor abrogates replication of subgenomic hepatitis C virus RNA.

scientific article published on 19 March 2003

Antiviral effect, safety, and pharmacokinetics of five-day oral administration of Deleobuvir (BI 207127), an investigational hepatitis C virus RNA polymerase inhibitor, in patients with chronic hepatitis C.

scientific article published on 15 July 2013

Baseline hepatitis C virus (HCV) NS3 polymorphisms and their impact on treatment response in clinical studies of the HCV NS3 protease inhibitor faldaprevir

scientific article published on 11 November 2013

Binding site characterization and resistance to a class of non-nucleoside inhibitors of the hepatitis C virus NS5B polymerase

scientific article published on 27 September 2005

Discovery of BI 207524, an indole diamide NS5B thumb pocket 1 inhibitor with improved potency for the potential treatment of chronic hepatitis C virus infection

scientific article published on 25 November 2014

Evaluating acute pain intensity relief: challenges when using an 11-point numerical rating scale

scientific article published on 6 October 2015

In vitro resistance profile of the hepatitis C virus NS3 protease inhibitor BI 201335.

scientific article published on 24 October 2011

Molecular dynamics simulations and structure-based rational design lead to allosteric HCV NS5B polymerase thumb pocket 2 inhibitor with picomolar cellular replicon potency

scientific article

Non-nucleoside benzimidazole-based allosteric inhibitors of the hepatitis C virus NS5B polymerase: inhibition of subgenomic hepatitis C virus RNA replicons in Huh-7 cells

scientific article published on December 2004

Protease and helicase activities of hepatitis C virus genotype 4, 5, and 6 NS3-NS4A proteins

scientific article published on 26 November 2009

Rapid and strong antiviral activity of the non-nucleosidic NS5B polymerase inhibitor BI 207127 in combination with peginterferon alfa 2a and ribavirin

scientific article published on 10 March 2012

Resistance Analyses of HCV NS3/4A Protease and NS5B Polymerase from Clinical Studies of Deleobuvir and Faldaprevir

scientific article published on 5 August 2016

Risk of Delayed Intracranial Hemorrhage in Anticoagulated Patients with Mild Traumatic Brain Injury: Systematic Review and Meta-Analysis

scientific article

Safety, pharmacokinetics and antiviral effect of BILB 1941, a novel hepatitis C virus RNA polymerase inhibitor, after 5 days oral treatment

scientific article published on January 2009

The simple query "Do you want more pain medication?" is not a reliable way to assess acute pain relief in patients in the emergency department

scientific article published on 15 March 2017

Viral resistance in hepatitis C virus genotype 1-infected patients receiving the NS3 protease inhibitor Faldaprevir (BI 201335) in a phase 1b multiple-rising-dose study

scientific article published on 22 July 2013